Research Compounds

ActRIIB-Fc decoy receptor studied for myostatin and GDF-11 inhibition pathway research. Investigated in muscular dystrophy and sarcopenia preclinical models.

Body Protection Compound studied extensively in gastric and musculoskeletal research models for its effects on growth factor expression and tissue signaling pathways.

Combined BPC-157 and TB-500 (Thymosin Beta-4) blend for synergistic tissue repair signaling research. Both compounds studied in healing and recovery models.

GHRH analogue with Drug Affinity Complex studied for prolonged GH secretion effects and extended half-life characteristics in research models.

Modified GHRH fragment studied for its shorter-acting pulsatile GH-releasing activity in cell and animal models.

Classic GHRH + GHRP combination studied for synergistic pulsatile GH secretion, somatotroph axis stimulation, and body composition pathway research.

Activin-binding glycoprotein studied for myostatin inhibition, FSH suppression, and muscle fiber hypertrophy signaling in musculoskeletal research.

Second-generation growth hormone releasing peptide studied for potent GH secretagogue activity with minimal cortisol/prolactin effects in research models.

Growth hormone releasing hexapeptide studied for its ghrelin receptor agonist activity and GH secretion effects in preclinical research.

Glycoprotein hormone studied for LH receptor activation, Leydig cell steroidogenesis stimulation, and follicular development research in reproductive biology.

Potent synthetic GHRP studied for GH secretagogue activity and cardiac receptor binding properties in preclinical models.

Recombinant human growth hormone (191 amino acid sequence) studied for GH receptor binding, IGF-1 axis activation, and anabolic pathway research.

FSH/LH gonadotropin blend studied for follicular stimulation, spermatogenesis, and steroidogenesis pathway research in reproductive biology models.

Long R3 IGF-1 analogue with extended half-life studied for its anabolic signaling, myogenesis, and protein synthesis pathway effects in research models.

Selective growth hormone secretagogue studied for its GH-releasing effects with high receptor selectivity in in-vitro and animal research models.

IGF-1 splice variant studied for its role in satellite cell activation and muscle fiber repair signaling in mechanical stress research models.

Oral ghrelin mimetic studied for sustained GH/IGF-1 axis stimulation, sleep architecture effects, and nitrogen retention in research models.

Synthetic GHRH analogue (first 29 amino acids) studied for natural pulsatile GH secretion effects in hypothalamic-pituitary axis research.

Thymic peptide researched for its role in actin regulation, cell migration, angiogenesis, and wound healing signaling in preclinical models.

Synthetic GHRH analogue studied for visceral adipose reduction, GH/IGF-1 axis stimulation, and body composition effects in metabolic research.